Clinical trial · Interventional
Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC
A Randomized Prospective Multicenter Study Comparing Fibula Free-flap Mandibular Reconstruction With or Without Preoperative Virtual Planning in Patients With Oral or Oropharyngeal Cancer
NCT04725396CI-TRIAL-00097624CURVEcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a national multicenter, randomized, stratified, open label study, aiming to compare mandibular reconstruction (MR) with or without preoperative virtual planning (PVP), in patients with oral/oropharyngeal cancer (OOPC).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oral Cavity Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Oropharynx Squamous Cell Carcinoma | Oropharynx Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Conventional Mandibular Reconstruction (MR without PVP) | Device | — | UNRESOLVED |
| Mandibular Reconstruction (MR) with Preoperative Virtual Planning (PVP). | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Patients undergoing PVP-assisted MR
- description
- PVP is based on CT-scan with millimetric thin slice acquisitions of the facial bone and fibulas. The surgeon defines the exact sites of the intended mandibular osteotomies. A single external subcontracted laboratory (Materialise®) produces the various cutting guides for mandibular resection, flap conformation and the preformed plates for flap osteosynthesis. Flap conformation is entirely performed at the donor site before section of the vascular pedicle (flap still vascularized).
- interventionNames
- Device: Mandibular Reconstruction (MR) with Preoperative Virtual Planning (PVP).
- type
- ACTIVE_COMPARATOR
- label
- Patients undergoing conventional (i.e. without PVP) MR
- description
- Flap modeling and positioning requires one or multiple cuneiform osteotomies. The bone transplant is shaped to restore the contours of the mandibular defect using preoperative imaging studies and the resection specimen. Flap conformation begins at the donor site and is generally completed at the recipient site after fibular pedicle section and before microvascular anastomosis (during ischemia time). The different bone fragments are fixed together and to the native mandible using either titanium miniplates or reconstruction plate and monocortical screws. Regardless of the material used for fixing the fibular flap to the native mandible, the use of a reconstruction plate adapted to the native mandible (or other similar techniques) prior to tumor resection is recommended to guide flap shaping and positioning, and to insure an accurate MR.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Aged 18 years or over 2. Primary or recurrent OOPC, histologically proven, requiring segmental mandibulectomy 3. Planned immediate fibula free flap MR to be performed at the same time as the tumor ablation by segmental mandibulectomy 4. MR requiring at least one osteotomy for contouring the flap (i.e. at least 2 bone fragments) 5. East Cooperative Oncology Group (ECOG) performance status 0 or 1 6. American Society of Anesthesiologists Physical Status (ASA) score 1, 2, or 3 7. Patients considered fit for surgery as decided by the multidisciplinary team 8. Patients must be willing and able to comply with the protocol for the duration of the study including scheduled visits, treatment plan, laboratory tests and other study procedures 9. Patients must be affiliated to a Social Security System (or equivalent) 10. Patients must have signed a written informed consent form prior to any trial specific procedures. If the patients are physically unable to give their written consent, a trusted person of their choice, not related to the investigator or the sponsor, can confirm in writing the patient's consent Exclusion Criteria: 1. Non resectable tumors (T4b primary tumor, non resectable metastatic lymph nodes) 2. Comorbidities factors that would contraindicate surgery (such as severe peripheral artery disease) 3. MR requiring no osteotomy for contouring the flap (i.e. one bone fragment) 4. Patients with distant metastatic disease as determined by routine pre-operative staging radiological investigations e.g. CT thorax and upper abdomen or positron emission tomography (PET)-CT 5. Other uncontrolled malignancy 6. Serious, non-healing or dehiscing wound, active ulcer or ongoing bone fracture at the free-flap donor site 7. Patients unwilling or unable to comply with the medical follow-up required by the trial because of psychosocial, familial, social, or geographical reasons 8. Participation in another clinical study with an investigational medicinal product during the last 30 days prior to inclusion 9. Patients deprived of their liberty or under protective custody or guardianship
References
Publications (0)
Data not yet available
No reference posted for this study.